Your browser doesn't support javascript.
loading
Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.
Venugopal, N; Bhaskar Reddy, A Vijaya; Gangadhar Reddy, K; Madhavi, V; Madhavi, G.
Afiliación
  • Venugopal N; Department of Chemistry, Sri Venkateswara University, Tirupati, AP 517502, India.
J Pharm Biomed Anal ; 70: 592-7, 2012 Nov.
Article en En | MEDLINE | ID: mdl-22749172
ABSTRACT
A sensitive and selective liquid chromatographic-tandem mass spectrometric (LC/MS/MS) method was developed and validated for the trace analysis (>1 ppm level) of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole sodium drug substances. LC/MS/MS analysis of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride was done on Hypersil BDS C18 (50 mm × 4.6 mm) 3 µm column and 10 mM ammonium acetate in 1000 mL of water was used as buffer. The mobile phase used was in the ratio of buffer-acetonitrile (7921, v/v). The flow rate was 1.0 mL/min and elution was monitored at 210 nm. The method was validated as per International Conference on Harmonization (ICH) guidelines. LC/MS/MS is able to quantitate up to 0.3 ppm of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Contaminación de Medicamentos / Cromatografía Líquida de Alta Presión / 2-Piridinilmetilsulfinilbencimidazoles / Espectrometría de Masas en Tándem / Inhibidores de la Bomba de Protones / Mutágenos Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: J Pharm Biomed Anal Año: 2012 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Contaminación de Medicamentos / Cromatografía Líquida de Alta Presión / 2-Piridinilmetilsulfinilbencimidazoles / Espectrometría de Masas en Tándem / Inhibidores de la Bomba de Protones / Mutágenos Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: J Pharm Biomed Anal Año: 2012 Tipo del documento: Article País de afiliación: India